Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives.

Cuascut FX, Hutton GJ.

Biomedicines. 2019 Mar 30;7(2). pii: E26. doi: 10.3390/biomedicines7020026. Review.

2.

Advanced neuroimaging in Balo's concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year.

Yeo CJJ, Hutton GJ, Fung SH.

Radiol Case Rep. 2018 Jun 1;13(5):1030-1035. doi: 10.1016/j.radcr.2018.04.010. eCollection 2018 Oct.

3.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD.

Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.

4.

Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis.

Mandel JJ, Goethe EA, Patel AJ, Heck K, Hutton GJ.

J Neurol Sci. 2016 Oct 15;369:51-52. doi: 10.1016/j.jns.2016.07.024. Epub 2016 Jul 12. No abstract available.

PMID:
27653865
5.

Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.

Yapundich R, Applebee A, Bethoux F, Goldman MD, Hutton GJ, Mass M, Pardo G, Klingler M, Henney HR 3rd, Blight AR, Carrazana EJ.

Int J MS Care. 2015 May-Jun;17(3):138-45. doi: 10.7224/1537-2073.2014-040.

6.

Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimod.

Schurmann P, Basra S, Awar OG, Aguilar D, Basant A, Dragan E, Hutton GJ, Birnbaum Y.

Mult Scler Relat Disord. 2014 May;3(3):408-12. doi: 10.1016/j.msard.2013.11.001. Epub 2013 Nov 28.

PMID:
25876482
7.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

8.

IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.

Chen M, Chen G, Deng S, Liu X, Hutton GJ, Hong J.

J Neuroimmunol. 2012 Jan 18;242(1-2):39-46. doi: 10.1016/j.jneuroim.2011.10.014. Epub 2011 Nov 21.

PMID:
22112394
9.

The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.

Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, Rivera VM.

Int J MS Care. 2011 Summer;13(2):91-3. doi: 10.7224/1537-2073-13.2.91.

10.

Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis.

Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, Montague PR, Hutton GJ.

Front Hum Neurosci. 2010 Nov 22;4:219. doi: 10.3389/fnhum.2010.00219. eCollection 2010.

11.

Regulatory effects of interferon-β on osteopontin and interleukin-17 expression in multiple sclerosis.

Hong J, Hutton GJ.

J Interferon Cytokine Res. 2010 Oct;30(10):751-7. doi: 10.1089/jir.2010.0082. Review.

PMID:
20874252
12.

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.

Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M; ACT Investigators.

Neurology. 2009 Feb 10;72(6):535-41. doi: 10.1212/01.wnl.0000341934.12142.74.

PMID:
19204263
13.

Pneumocephalus after an epidural steroid injection.

Hutton GJ, Avila M, Suarez GA.

Clin Neurol Neurosurg. 2009 Apr;111(3):309-10. doi: 10.1016/j.clineuro.2008.10.009. Epub 2008 Nov 25. No abstract available.

PMID:
19036497
14.

Heart-shaped lesion secondary to neurosarcoidosis.

Suárez Zambrano GA, Hutton GJ.

Arch Neurol. 2008 Oct;65(10):1388-9. doi: 10.1001/archneur.65.10.1388. No abstract available.

PMID:
18852359
15.

Spectrum of pediatric neuromyelitis optica.

Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV.

Pediatrics. 2008 Nov;122(5):e1039-47. doi: 10.1542/peds.2007-2758. Epub 2008 Oct 6.

PMID:
18838462
16.

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.

Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H; ACT Investigators.

Mult Scler. 2008 Apr;14(3):370-82. doi: 10.1177/1352458507083189. Epub 2008 Jan 21.

PMID:
18208877
17.

Autologous HSCT for advanced MS: is the glass half-empty or really half-full?

Nash RA, Stuve O, Bowen JD, Frohman EM, Griffith LM, Hutton GJ, Kraft GH, Popat U, Racke MK, Muraro PA.

Brain. 2008 Feb;131(Pt 2):e89; author reply e90. Epub 2007 Sep 30. No abstract available.

PMID:
17908695
18.

The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis.

Bakshi R, Hutton GJ, Miller JR, Radue EW.

Neurology. 2004 Dec 14;63(11 Suppl 5):S3-11. Review.

PMID:
15596734
19.

Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.

Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, Zhang JZ.

Mult Scler. 2004 Oct;10(5):499-506.

PMID:
15471364

Supplemental Content

Loading ...
Support Center